Gao Feixia, Wang Qi, Qiu Chenchen, Luo Jian, Li Xiuling
Shanghai Institute of Biological Products, 200052, Shanghai, China.
Shanghai Institute of Biological Products, 200052, Shanghai, China.
Virol Sin. 2024 Dec;39(6):981-985. doi: 10.1016/j.virs.2024.11.005. Epub 2024 Nov 30.
• Analyzed the outbreak situation and viral characteristics of the newly H5N1 highly pathogenic avian influenza (HPAI) virus. • The current approval and research and development of the H5N1 HPAI vaccines were summarized. • Proposed vaccine development approaches against newly H5N1 virus, e.g. adjuvanted vaccine, mRNA vaccine, multivalent vaccine. • Discussed other prevention and control strategies, e.g. poultry vaccination, global surveillance and comprehensive testing.
• 分析了新型H5N1高致病性禽流感(HPAI)病毒的暴发情况和病毒特征。
• 总结了H5N1 HPAI疫苗目前的获批情况及研发进展。
• 提出了针对新型H5N1病毒的疫苗研发方法,如佐剂疫苗、mRNA疫苗、多价疫苗。
• 讨论了其他防控策略,如家禽疫苗接种、全球监测和全面检测。